Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Pathfinder CEO switch pushes co-founder’s focus back to autism research
A leadership change at Pathfinder Health Innovations will allow its co-founder to focus on research that could change the lives of children and adults with autism, said Jeff Blackwood. Pathfinder announced Tuesday its board had appointed Tina Youngblood as chief executive officer, succeeding co-founder Blackwood to lead day-to-day operations and the strategic direction for the…
KC native builds jumpsuits for all occasions — butt flap included
Party and potty in one easy piece. Literally. That’s the benefit of wearing a jumpsuit with a butt flap included: Users avoid the hassle of removing half the outfit to use the restroom, said Brittany Weltner. The Kansas City native just launched a crowdfunding campaign for her new business, Jomper, to build more functional jumpsuits…
‘Get a glimpse of your future’ — Investors want data with your pitch
Editor’s Note: This content is sponsored by Mid-Continent Public Library but independently produced by Startland News. For more on the tools discussed in this article, click here. Imagine this. Your wearable tech firm is thriving — so much, in fact, that you need an injection of investment capital to maintain sustainable growth. You’ve booked some…
Launch It Successfully hopes to reduce early stage frustration, struggle for startups
A new accelerator program produced by key leaders of software development firm Illumisoft is helping innovators start their businesses by “cutting through the nonsense,” said Tyler Prince. “We want to help entrepreneurs succeed,” he said. “I think we live in an age when change happens so rapidly.” Launch It Successfully’s goal is to assist early…